Table 1 Participant demographics
N | Mean (CI) | n (%) | |
|---|---|---|---|
Age, yrs | 460 | 51 (50–53) | |
Female, n | 460 | 299 (65) | |
FEV1, L | 457 | 2.12 (2.05–2.20) | |
FEV1, % predicted | 454 | 71.75 (69.79–73.71) | |
Caucasian, n | 460 | 416 (91) | |
BMI, kg/m2 | 459 | 31.10 (30.39–31.81) | |
Prescribed maintenance OCS, n | 460 | 218 (47) | |
Exacerbations in the last 12 months requiring OCS, n | 460 | 3.74 (3.35–4.12) | |
Emergency Department visits | 460 | 0.91 (0.66–1.15) | |
Hospital visits | 460 | 0.65 (0.43–0.87) | |
Cumulative prednisolone, mg/yr | 460 | 3148 (2814–3483) | |
Receiving biologics, n | 456 | 180 (39) |